OTLKOutlook Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Outlook Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OTLKThis | $166M#8 | — | — | 117.4x#9 | — | 17.2%#3 | -4744.3%#8 | — | -12.8%#1 | — | -33.8%#8 | — |
| ALEC | $206M#1 | — | — | 9.8x#5 | -79.1%#5 | -20.2%#6 | -741.3%#6 | — | — | — | -37.4%#9 | — |
| SRZN | $200M#2 | — | — | 57.6x#7 | -67.4%#4 | -280.8%#11 | -1210.6%#7 | — | — | — | 43.9%#2 | — |
| CHRS | $190M#4 | — | 3.1x#4 | 4.5x#1 | 59.8%#1 | 489.4%#1 | -429.5%#4 | 276.2%#2 | -351.2%#2 | — | -9.2%#6 | — |
| ACOG | $193M#3 | — | 3.6x#7 | 18.9x#6 | — | -39.8%#7 | -221.7%#2 | -39.0%#4 | — | — | 6.1%#5 | — |
| VYGR | $186M#5 | — | 1.2x#3 | 4.6x#2 | -49.5%#2 | -84.2%#9 | -326.6%#3 | -77.6%#6 | — | — | -29.2%#7 | — |
| ABOS | $184M#6 | — | 3.2x#5 | — | — | -18.6%#5 | — | -211.9%#9 | -421.4%#3 | — | 102.0%#1 | — |
| DTIL | $177M#7 | — | 3.9x#8 | 5.2x#3 | -50.1%#3 | -738.0%#12 | -152.2%#1 | -101.0%#7 | — | — | 41.0%#4 | — |
| HUMA | $159M#9 | — | 5.1x#9 | 78.0x#8 | — | 72.5%#2 | -5306.0%#9 | -130.6%#8 | — | — | -62.6%#11 | — |
| ARMP | $155M#10 | — | — | — | — | -818.8%#13 | — | — | — | — | 41.5%#3 | 0.1%#1 |
| NMRA | $144M#11 | — | 3.2x#6 | — | — | -2.8%#4 | — | 532.2%#1 | -594.0%#4 | — | -46.5%#10 | — |
| LENZ | $126M#13 | — | 0.6x#2 | 6.6x#4 | — | -65.0%#8 | -477.5%#5 | -37.5%#3 | — | — | -90.5%#13 | — |
| ENGN | $127M#12 | 0.8x#1 | 0.6x#1 | — | — | -112.7%#10 | — | -50.9%#5 | — | — | -69.6%#12 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice